Feature image

What's New

Prescriber Update 47(2) June 2026

We've published the latest issue of Prescriber Update.

This issue contains information about adverse effects from inappropriate use of topical corticosteroids, undesirable effects of opioids, reported adverse reactions to ashwagandha, and more.

Prescriber Update 47(2) June 2026

News and Events

Date Type Title
28/8/2026ConsultationOutcome of the consultation on proposed changes to the classification of vitamin D pursuant to the Medicines Regulations 1984
28/8/2026CommitteesMedicines Adverse Reactions Committee - vacancies for specialist clinicians
24/8/2026ConsultationOutcome of the consultation on changes to clozapine blood monitoring and prescribing requirements
24/8/2026CommitteesAgenda for the 76th Medicines Classification Committee meeting
24/8/2026CommitteesMedicines Classification Committee - Dates and Deadlines
4/8/2026NoticesUpdate to guideline to include extension of the types of medicine labels eligible for a general labelling exemption
2/7/2026NoticesMedsafe Industry Day - 11 August 2026
29/6/2026NoticesGuideline on the Regulation of Therapeutic Products in New Zealand - Verification Pathway for New Medicine Applications, Edition 1.0, July 2026